Neutrophil-to-Lymphocyte Ratio (NLR) as a Biomarker in Clinically Stable Chronic Obstructive Pulmonary Disease: SPIROMICS cohort

Hoesterey DT, Dang H, Markovic D, Buhr RG, Tashkin DP, Barr RG, Belperio JA, Bowler RP, Bleecker ER, Couper DJ, Criner GG, Cooper CB, Doerschuk CM, Dransfield MT, Drummond MB, Fawzy A, Freeman CM, Han MK, Hansel NN, Hastie AT, Hoffman EA, Huang YJ, Kaner RJ, Kanner RE, Kim V, Krishnan JA, Martinez FJ, O'Neal WK, Ortega VE, Paine R 3rd, Shrivastav AK, Wells JM, Woodruff PG, Curtis JL, Barjaktarevic I. Neutrophil-to-Lymphocyte Ratio (NLR) as a Biomarker in Clinically Stable Chronic Obstructive Pulmonary Disease: SPIROMICS cohort. Ann Am Thorac Soc. 2025 Sep 8. doi: 10.1513/AnnalsATS.202412-1265OC. Epub ahead of print. PMID: 40920896.


Related Posts